Agriculture Secretary Brooke Rollins is expected “in the coming days” to announce a new strategy to fight the escalating outbreak.

TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.

There is new hope when it comes to egg prices. A company producing a bird flu vaccine has now been granted conditional approval from the United States Department of Agriculture. While this current strain of the avian flu has been top of mind for the past few months,

The illness, which infects chickens and many other birds, has pushed egg prices through the roof in the past few months. Vaccinating flocks, however, could hurt the poultry industry on the global market.

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.

Over the last 30 days, 151 flocks have been confirmed to have avian flu, affecting more than 23 million birds, according to the Animal Planet Health Inspection Service part of the USDA. Dr. Paul Offit, of the FDA Vaccine Advisory Committee, says people could also become sick.

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due to the virus. This month, the USDA granted a conditional license to Zoetis for its Avian Influenza Vaccine.

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.